QIAGEN N.V. Deferred Revenue Recognized
QIAGEN N.V. (QGEN) reported Deferred Revenue Recognized of $75.80 million for the 12-month period ending 2025-12-31, per its 20-F filed 2026-03-20.
Financial Statements › Income Statement › Other Income
us-gaap:ContractWithCustomerLiabilityRevenueRecognized · last filed 2026-03-20
| Period end | Contract with Customer, Liability, Revenue Recognized 12 month |
|---|---|
| 2025-12-31 | $75.80M 20-F · filed 2026-03-20 |
| 2024-12-31 | $75.50M 20-F · filed 2026-03-20 |
| 2023-12-31 | $66.80M 20-F · filed 2025-03-31 |
| 2022-12-31 | $57.60M 20-F · filed 2024-03-11 |
| 2021-12-31 | $54.90M 20-F · filed 2023-03-13 |
| 2020-12-31 | $48.10M 20-F · filed 2022-03-14 |
| 2019-12-31 | $48.30M 20-F · filed 2021-03-05 |
| 2018-12-31 | $44.50M 20-F · filed 2020-03-02 |